GTCM
LUNG icon

Gyon Technologies Capital Management’s Pulmonx LUNG Stock Holding History

Gyon Technologies Capital Management’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-15,045
Closed -$221K – 509
2022
Q2 		$221K Buy
+15,045
New +$310K 0.06% 378

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Gyon Technologies Capital Management's LUNG Position: Q3 2022 in Review

Gyon Technologies Capital Management sold out of Pulmonx (LUNG) in Q3 2022, closing a stake of 15,045 shares — an estimated $221K sold.

Gyon Technologies Capital Management first reported a position in LUNG in Q2 2022 and held it in 1 quarter. The position peaked at $221K in Q2 2022. 104 funds tracked by Wall St. Rank hold LUNG as of Q3 2022.

  • Gyon Technologies Capital Management reported no remaining Pulmonx position as of Q3 2022 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 15,045 Pulmonx shares in Q3 2022, an estimated $221K.
  • Gyon Technologies Capital Management first reported a position in Pulmonx in Q2 2022 and held it in 1 quarter.
  • Gyon Technologies Capital Management's Pulmonx position peaked at $221K in Q2 2022.
  • 104 funds tracked by Wall St. Rank held Pulmonx as of Q3 2022.

Based on Gyon Technologies Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.